Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitors
T
Thomas C. Eadsforth
L
Leah S. Torrie
P
Paul Rowland
E
Emma V. Edgar
L
Lorna M. MacLean
C
Christy Paterson
D
David A. Robinson
S
Sharon M. Shepherd
J
John Thomas
M
Michael G. Thomas
D
David W. Gray
V
Vincent L.G. Postis
M
Manu De Rycker
Article Details
Journal
Journal of Biological Chemistry
Volume / Issue
Vol. 301, Issue 1
Published
January 01, 2025
Pages
108049
ISSN
0021-9258
Publisher
Elsevier BV
Authors (13)
T
Thomas C. Eadsforth
L
Leah S. Torrie
P
Paul Rowland
E
Emma V. Edgar
L
Lorna M. MacLean
C
Christy Paterson
D
David A. Robinson
S
Sharon M. Shepherd
J
John Thomas
M
Michael G. Thomas
D
David W. Gray
V
Vincent L.G. Postis
M
Manu De Rycker
Related Articles from this Journal
Asialoglycoprotein receptor subunit Asgr1a loss results in attenuated cholesterol absorption in zebrafish fed a western diet
Joshua T. Derrick, Tabea O.C. Moll et al.
Aug 2026
10.1016/j.jbc.2026.113239
Nrf2-mediated epigenetic priming of osmoprotective genes enhances cellular adaptation to hyperosmotic stress
Yi Lu, Na Li et al.
Aug 2026
10.1016/j.jbc.2026.113278
Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function
Kailash Venkatraman, Daniel Milshteyn et al.
Aug 2026
10.1016/j.jbc.2026.113306
Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression
Katerina-Marina Pilala, Artemis-Melina Papadimitriou et al.
Aug 2026
10.1016/j.jbc.2026.113302
Correction: Abstract 5588 Multifunctional carbon dots nanocarriers: Dual-drug delivery via π-π stacking interaction for stimuli-responsive chemotherapy and high oxidative stress
Girum Demissie, Jia Chang
Aug 2026
10.1016/j.jbc.2026.113253